149 related articles for article (PubMed ID: 37431668)
1. Human lysozyme inhibits the fibrillation of serum amyloid a protein from systemic AA amyloidosis.
Moderer T; Puşcalău-Gîrţu I; Haupt C; Baur J; Rodríguez-Alfonso A; Wiese S; Schmidt CQ; Malešević M; Forssmann WG; Ständker L; Fändrich M
Amyloid; 2023 Dec; 30(4):424-433. PubMed ID: 37431668
[TBL] [Abstract][Full Text] [Related]
2. AA amyloid fibrils from diseased tissue are structurally different from in vitro formed SAA fibrils.
Bansal A; Schmidt M; Rennegarbe M; Haupt C; Liberta F; Stecher S; Puscalau-Girtu I; Biedermann A; Fändrich M
Nat Commun; 2021 Feb; 12(1):1013. PubMed ID: 33579941
[TBL] [Abstract][Full Text] [Related]
3. Transmission of systemic AA amyloidosis in animals.
Murakami T; Ishiguro N; Higuchi K
Vet Pathol; 2014 Mar; 51(2):363-71. PubMed ID: 24280941
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of amyloid proteins.
Benson MD; Kluve-Beckerman B; Liepnieks JJ; Murrell JR; Hanes D; Uemichi T
Ciba Found Symp; 1996; 199():104-13; discussion 113-8. PubMed ID: 8915606
[TBL] [Abstract][Full Text] [Related]
5. AA-amyloidosis in cats (Felis catus) housed in shelters.
Ferri F; Ferro S; Porporato F; Callegari C; Guglielmetti C; Mazza M; Ferrero M; Crinò C; Gallo E; Drigo M; Coppola LM; Gerardi G; Schulte TP; Ricagno S; Vogel M; Storni F; Bachmann MF; Vogt AC; Caminito S; Mazzini G; Lavatelli F; Palladini G; Merlini G; Zini E
PLoS One; 2023; 18(3):e0281822. PubMed ID: 36989207
[TBL] [Abstract][Full Text] [Related]
6. Aggregation of Mouse Serum Amyloid A Protein Was Promoted by Amyloid-Enhancing Factors with the More Genetically Homologous Serum Amyloid A.
Lin X; Watanabe K; Kuragano M; Tokuraku K
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494290
[TBL] [Abstract][Full Text] [Related]
7. N-terminal peptide fragment constitutes core of amyloid deposition of serum amyloid A: An imaging mass spectrometry study.
Shintani-Domoto Y; Sugiura Y; Ogawa M; Sugiyama E; Abe H; Sakatani T; Ohashi R; Ushiku T; Fukayama M
PLoS One; 2022; 17(10):e0275993. PubMed ID: 36240260
[TBL] [Abstract][Full Text] [Related]
8. Animal models for reactive amyloidosis.
Gruys E; Snel FW
Baillieres Clin Rheumatol; 1994 Aug; 8(3):599-611. PubMed ID: 7954864
[TBL] [Abstract][Full Text] [Related]
9. Investigation of serum amyloid a within animal species focusing on the 1-25 amino acid region.
Horgan NG; Moore KBE; Fortin JS
Vet Q; 2023 Dec; 43(1):1-8. PubMed ID: 37800590
[TBL] [Abstract][Full Text] [Related]
10. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein.
Gillmore JD; Lovat LB; Persey MR; Pepys MB; Hawkins PN
Lancet; 2001 Jul; 358(9275):24-9. PubMed ID: 11454373
[TBL] [Abstract][Full Text] [Related]
11. Proteolysis of serum amyloid A and AA amyloid proteins by cysteine proteases: cathepsin B generates AA amyloid proteins and cathepsin L may prevent their formation.
Röcken C; Menard R; Bühling F; Vöckler S; Raynes J; Stix B; Krüger S; Roessner A; Kähne T
Ann Rheum Dis; 2005 Jun; 64(6):808-15. PubMed ID: 15897303
[TBL] [Abstract][Full Text] [Related]
12. Dietary Intake of Rosmarinic Acid Increases Serum Inhibitory Activity in Amyloid A Aggregation and Suppresses Deposition in the Organs of Mice.
Lin X; Watanabe K; Kuragano M; Kurotaki Y; Nakanishi U; Tokuraku K
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825797
[TBL] [Abstract][Full Text] [Related]
13. Characterization of amyloid A protein in human secondary amyloidosis: the predominant deposition of serum amyloid A1.
Liepnieks JJ; Kluve-Beckerman B; Benson MD
Biochim Biophys Acta; 1995 Jan; 1270(1):81-6. PubMed ID: 7827140
[TBL] [Abstract][Full Text] [Related]
14. Induction of murine AA amyloidosis by various homogeneous amyloid fibrils and amyloid-like synthetic peptides.
Liu Y; Cui D; Hoshii Y; Kawano H; Une Y; Gondo T; Ishihara T
Scand J Immunol; 2007 Nov; 66(5):495-500. PubMed ID: 17953525
[TBL] [Abstract][Full Text] [Related]
15. Influence of the carboxy terminus of serum amyloid A on protein oligomerization, misfolding, and fibril formation.
Patke S; Maheshwari R; Litt J; Srinivasan S; Aguilera JJ; Colón W; Kane RS
Biochemistry; 2012 Apr; 51(14):3092-9. PubMed ID: 22448726
[TBL] [Abstract][Full Text] [Related]
16. Cryo-EM fibril structures from systemic AA amyloidosis reveal the species complementarity of pathological amyloids.
Liberta F; Loerch S; Rennegarbe M; Schierhorn A; Westermark P; Westermark GT; Hazenberg BPC; Grigorieff N; Fändrich M; Schmidt M
Nat Commun; 2019 Mar; 10(1):1104. PubMed ID: 30846696
[TBL] [Abstract][Full Text] [Related]
17. Amyloid fibril structure from the vascular variant of systemic AA amyloidosis.
Banerjee S; Baur J; Daniel C; Pfeiffer PB; Hitzenberger M; Kuhn L; Wiese S; Bijzet J; Haupt C; Amann KU; Zacharias M; Hazenberg BPC; Westermark GT; Schmidt M; Fändrich M
Nat Commun; 2022 Nov; 13(1):7261. PubMed ID: 36433936
[TBL] [Abstract][Full Text] [Related]
18. Methods to study the structure of misfolded protein states in systemic amyloidosis.
Fändrich M; Schmidt M
Biochem Soc Trans; 2021 Apr; 49(2):977-985. PubMed ID: 33929491
[TBL] [Abstract][Full Text] [Related]
19. Human SAA1-derived amyloid deposition in cell culture: a consistent model utilizing human peripheral blood mononuclear cells and serum-free medium.
Ishii W; Liepnieks JJ; Yamada T; Benson MD; Kluve-Beckerman B
Amyloid; 2013 Jun; 20(2):61-71. PubMed ID: 23461622
[TBL] [Abstract][Full Text] [Related]
20. The pathogenesis and biochemistry of amyloidosis.
Cohen AS; Connors LH
J Pathol; 1987 Jan; 151(1):1-10. PubMed ID: 3550020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
